Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin and Rifampicin for OsteoArticular Prosthetic Infections
NCT00906048Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Apr 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levofloxacin in Prosthetic Joint Infection (PJI), sponsored by Sanofi. Started Apr 2009; status: terminated.
02
Drugs
levofloxacin
03
Conditions
Prosthetic Joint Infection (PJI)
Beyond the preview
Go deeper on NCT00906048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00906048.